Gary M. Mobley

1.0k total citations
27 papers, 828 citations indexed

About

Gary M. Mobley is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Gary M. Mobley has authored 27 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Hematology. Recurrent topics in Gary M. Mobley's work include Cancer survivorship and care (8 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Cancer Treatment and Pharmacology (6 papers). Gary M. Mobley is often cited by papers focused on Cancer survivorship and care (8 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Cancer Treatment and Pharmacology (6 papers). Gary M. Mobley collaborates with scholars based in United States. Gary M. Mobley's co-authors include Charles S. Cleeland, Xin Shelley Wang, Tito R. Mendoza, Zhongxing Liao, Qiuling Shi, Guadalupe R. Palos, Loretta A. Williams, Li Mao, Charles Lu and Sergio Giralt and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Gary M. Mobley

25 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary M. Mobley United States 9 529 276 258 147 88 27 828
Amber S. Kleckner United States 17 872 1.6× 372 1.3× 389 1.5× 152 1.0× 31 0.4× 61 1.3k
Larry Driver United States 18 555 1.0× 327 1.2× 248 1.0× 256 1.7× 62 0.7× 32 1.1k
Mohammed S. Ogaily United States 4 441 0.8× 247 0.9× 173 0.7× 58 0.4× 69 0.8× 5 598
D. Storey United Kingdom 12 541 1.0× 201 0.7× 171 0.7× 143 1.0× 45 0.5× 22 858
Paula M Geigle United States 6 1.2k 2.3× 656 2.4× 334 1.3× 130 0.9× 27 0.3× 6 1.7k
Hester Hill Schnipper United States 5 556 1.1× 307 1.1× 223 0.9× 113 0.8× 15 0.2× 10 948
M. Hofman United States 4 575 1.1× 312 1.1× 263 1.0× 64 0.4× 16 0.2× 11 804
Debra R. Berlanstein United States 8 1.1k 2.0× 588 2.1× 299 1.2× 111 0.8× 21 0.2× 9 1.4k
Morten Quist Denmark 21 1.4k 2.6× 752 2.7× 547 2.1× 135 0.9× 56 0.6× 34 1.8k
Katharina Schmidt Germany 15 351 0.7× 164 0.6× 182 0.7× 39 0.3× 67 0.8× 40 752

Countries citing papers authored by Gary M. Mobley

Since Specialization
Citations

This map shows the geographic impact of Gary M. Mobley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary M. Mobley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary M. Mobley more than expected).

Fields of papers citing papers by Gary M. Mobley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary M. Mobley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary M. Mobley. The network helps show where Gary M. Mobley may publish in the future.

Co-authorship network of co-authors of Gary M. Mobley

This figure shows the co-authorship network connecting the top 25 collaborators of Gary M. Mobley. A scholar is included among the top collaborators of Gary M. Mobley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary M. Mobley. Gary M. Mobley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xin Shelley, Loretta A. Williams, Sunil Krishnan, et al.. (2012). Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behavior and Immunity. 26(5). 699–705. 93 indexed citations
2.
Wang, Xin Shelley, David R. Fogelman, Qiuling Shi, et al.. (2012). Patient-reported symptoms from patients with advanced pancreatic cancer undergoing gemcitabine-based chemotherapy.. Journal of Clinical Oncology. 30(4_suppl). 370–370. 2 indexed citations
3.
Cleeland, Charles S., Tito R. Mendoza, Xin Shelley Wang, et al.. (2011). Levels of Symptom Burden During Chemotherapy for Advanced Lung Cancer: Differences Between Public Hospitals and a Tertiary Cancer Center. Journal of Clinical Oncology. 29(21). 2859–2865. 37 indexed citations
4.
Williams, Lorraine, Araceli García-González, Tito R. Mendoza, et al.. (2011). A new symptom measure in chronic myeloid leukemia.. Journal of Clinical Oncology. 29(15_suppl). e19545–e19545. 2 indexed citations
5.
Wang, Xin Shelley, Qiuling Shi, Loretta A. Williams, et al.. (2010). Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behavior and Immunity. 24(6). 968–974. 147 indexed citations
6.
Williams, Loretta A., Araceli García-González, Patricia Ault, et al.. (2010). Symptom Burden In Patients with Chronic Myeloid Leukemia (CML) on Kinase Inhibitor (KI) Therapy.. Blood. 116(21). 3838–3838. 3 indexed citations
7.
Wang, Xin Shelley, Qiuling Shi, Charles Lu, et al.. (2009). Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer. 116(1). 137–145. 64 indexed citations
8.
Williams, Loretta A., Karen O. Anderson, Xin Shelley Wang, et al.. (2009). Patterns of Symptom Burden in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.. Blood. 114(22). 1396–1396. 1 indexed citations
9.
Giralt, Sergio, et al.. (2009). Measuring the Symptom Burden of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With and Without Acute Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 15(2). 20–21. 7 indexed citations
10.
Johnson, Valen E., et al.. (2009). Association of sTNF-R1 and the development of treatment-related symptoms in patients undergoing concurrent chemoradiation therapy for colorectal or esophageal cancer. Journal of Clinical Oncology. 27(15_suppl). 3041–3041. 1 indexed citations
11.
Wang, Xin Shelley, Qiuling Shi, Lori Williams, et al.. (2008). Serum interleukin‐6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer. 113(8). 2102–2109. 62 indexed citations
12.
Williams, Loretta A., Patricia Ault, Xin Shelley Wang, et al.. (2008). The Symptom Burden of Chronic Myelogenous Leukemia (CML). Blood. 112(11). 2408–2408. 5 indexed citations
13.
Williams, Loretta A., Sergio Giralt, Tito R. Mendoza, et al.. (2008). 267: Larger Stem Cell Dose is Associated with Decreased Symptom Severity after Autologous Stem Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 14(2). 98–99. 1 indexed citations
14.
Anderson, Karen O., Sergio Giralt, Tito R. Mendoza, et al.. (2007). Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplantation. 39(12). 759–766. 92 indexed citations
15.
Shi, Qingyu, et al.. (2007). Symptom burden and survival outcome: 3 cycles versus 6 cycles of chemotherapy in advanced NSCLC. Journal of Clinical Oncology. 25(18_suppl). 17054–17054. 2 indexed citations
16.
Palos, Guadalupe R., Scott B. Cantor, Lu Ann Aday, et al.. (2006). An Urban Community's Preferences for Hypothetical Outcomes of Analgesic Pain Treatment. Journal of Pain and Symptom Management. 32(5). 470–477. 1 indexed citations
17.
Palos, Guadalupe R., Tito R. Mendoza, Gary M. Mobley, Scott B. Cantor, & Charles S. Cleeland. (2006). Asking the Community About Cutpoints Used to Describe Mild, Moderate, and Severe Pain. Journal of Pain. 7(1). 49–56. 100 indexed citations
18.
Giralt, Sergio, Charles S. Cleeland, James M. Reuben, et al.. (2005). Measuring Multiple Symptoms and Inflammatory Cytokines Related to Acute GVHD in AML/MDS Patients under Allogeneic BMT.. Blood. 106(11). 1426–1426. 1 indexed citations
19.
Palos, Guadalupe R., Tito R. Mendoza, Gary M. Mobley, Scott B. Cantor, & Charles S. Cleeland. (2004). Clinical outcomes measurement. Journal of Pain. 5(3). S111–S111. 1 indexed citations
20.
Mobley, Gary M., et al.. (2002). Effect of calcium carbonate on the abrasive wear of melt processing equipment in filled systems. Journal of Vinyl and Additive Technology. 8(4). 271–277. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amber S. Kleckner Breakdown of academic impact, for papers by Larry Driver Breakdown of academic impact, for papers by Mohammed S. Ogaily Breakdown of academic impact, for papers by D. Storey Breakdown of academic impact, for papers by Paula M Geigle Breakdown of academic impact, for papers by Hester Hill Schnipper Breakdown of academic impact, for papers by M. Hofman Breakdown of academic impact, for papers by Debra R. Berlanstein Breakdown of academic impact, for papers by Morten Quist Breakdown of academic impact, for papers by Katharina Schmidt
Rankless by CCL
2026